It is a challenge for oncologists to distinguish patients with breast cancer who can forego adjuvant systemic treatment without negatively affecting survival from those who cannot. Risk prediction ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced a significant milestone for its flagship Oncotype DX Breast Recurrence Score®test: ...
OCEANIC-STROKE shows asundexian cuts ischemic stroke recurrence by 26% in patients taking standard antiplatelet therapy, with no major bleeding increase. Asundexian is a direct oral inhibitor of FXIa ...
Beijing has tightened its grip on Hong Kong in recent years, dimming hopes that the financial center will ever become a full democracy. The IRGC is one of the most powerful organizations in Iran, ...
Competition with China poses a challenge unlike any the United States has faced before. To meet the challenge, CFR’s new China Strategy Initiative will answer the questions that go to the heart of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results